Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

69.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
69.5K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

201
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PARL stabilizes mitochondrial BCL-2 via Nur77-mediated scaffolding as a therapeutic strategy for Parkinson's disease.

Cell death & disease·2025
Same author

Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits.

Schizophrenia research·2019
Same author

Acetylation of ezrin regulates membrane-cytoskeleton interaction underlying CCL18-elicited cell migration.

Journal of molecular cell biology·2019
Same author

A chromosome-level genome assembly of Pyropia haitanensis (Bangiales, Rhodophyta).

Molecular ecology resources·2019
Same author

Tuberculosis Infection in Chinese Patients with Giant Cell Arteritis.

Scientific reports·2019
Same author

Protective Effects of ACY-1215 Against Chemotherapy-Related Cognitive Impairment and Brain Damage in Mice.

Neurochemical research·2019

Related Experiment Video

Updated: May 8, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.6K

Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis.

Hua Fan1, Ruile Shen1, Junqiang Yan1

  • 1The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China.

Drug Design, Development and Therapy
|December 24, 2024
PubMed
Summary

Gut bacteria trigger pyroptosis, a cell death process, contributing to multiple sclerosis (MS) development. Modulating gut microbiota may offer new therapies for MS by targeting this inflammatory pathway.

Keywords:
gut microbiotagut-brain axismultiple sclerosisneuroinflammationpyroptosistherapeutic targets

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.6K
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.3K

Related Experiment Videos

Last Updated: May 8, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.6K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.6K
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.3K

Area of Science:

  • Neuroimmunology
  • Microbiome Research
  • Cellular Biology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS).
  • Gut microbiota dysbiosis is increasingly implicated in the pathogenesis of MS.
  • Pyroptosis, an inflammatory programmed cell death, is a key inflammatory mechanism.

Purpose of the Study:

  • To elucidate the role of pyroptosis, induced by gut microbiota, in MS pathogenesis.
  • To emphasize the significance of the gut-brain axis in MS.
  • To explore potential therapeutic strategies targeting the gut microbiota-pyroptosis axis.

Main Methods:

  • Comprehensive review of recent literature on gut microbiota, pyroptosis, and MS.
  • Analysis of mechanisms linking gut microbial products to immune dysregulation and CNS damage.
  • Evaluation of pyroptosis as a therapeutic target.

Main Results:

  • Gut microbiota dysbiosis in MS patients is characterized by reduced diversity and altered bacterial populations.
  • Pyroptosis exacerbates MS by releasing inflammatory cytokines and damaging CNS tissues.
  • Gut microbial metabolites and products (e.g., SCFAs, LPS) modulate immune responses and neuronal survival.

Conclusions:

  • Gut microbiota plays a pivotal role in triggering pyroptosis in MS.
  • Targeting the gut microbiota-pyroptosis pathway presents a promising therapeutic avenue for MS.
  • Modulating gut microbiota may mitigate inflammation and preserve neuronal integrity in MS patients.